The U.S. Subcutaneous Immunoglobulin Market is witnessing significant growth as advances in biologic therapies and home-based healthcare continue to transform the management of immune disorders. Increasing awareness of primary immunodeficiency diseases, improvements in plasma-derived therapeutics, and the growing preference for self-administered treatments are contributing to greater adoption...